查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1791490

全球人工器官及仿生學市場

Artificial Organs and Bionics
出版日期: | 出版商: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 英文 129 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

預計到 2030 年全球人工器官和仿生學市場規模將達到 710 億美元

全球人工器官和仿生學市場規模預計在2024年達到432億美元，預計2024年至2030年期間的複合年成長率為8.6%，到2030年將達到710億美元。人工器官是本報告分析的細分市場之一，預計其複合年成長率將達到10.0%，到分析期結束時規模將達到451億美元。人工仿生學細分市場在分析期間的複合年成長率預計為6.4%。

美國市場預計將達到 114 億美元，中國市場複合年成長率將達到 8.3%

美國人工器官和仿生學市場規模預計在2024年達到114億美元。作為世界第二大經濟體，中國預計到2030年市場規模將達到113億美元，在2024-2030年的分析期間內，複合年成長率為8.3%。其他值得關注的區域市場包括日本和加拿大，預計在分析期間內，這兩個市場的複合年成長率分別為8.1%和7.1%。在歐洲，預計德國市場的複合年成長率約為6.7%。

全球人工器官和仿生學市場—主要趨勢和促進因素摘要

人造器官和仿生學如何重新定義人類的壽命和功能？

人工器官和仿生技術正在徹底改變現代醫療格局，為器官衰竭或身體功能喪失的患者提供挽救生命和改善生活的替代方案。從人工心臟和腎臟到人工電子耳和仿生肢體，該領域將生物醫學工程與機器人技術、電子技術和先進材料融為一體。人工器官是器官移植的關鍵橋樑，也是器官捐贈者持續短缺時的長期解決方案。同時，仿生技術可以恢復運動、聽力和視力，使患者重新獲得獨立生活和生活品質。這些技術創新對於慢性病猖獗的老化社會尤其重要。神經介面、觸覺回饋和即時監控的整合使現代仿生技術比以往任何時候都更加靈敏和逼真。用於截癱患者復健和行動的外骨骼以及3D列印器官支架正在突破以前被認為不可能實現的極限。微型化、電池壽命和植入式生物感測器的不斷改進正在創造更智慧、更適合患者的設備。這種學科融合正在推動醫療保健走向未來，屆時殘疾不再是永久性的限制，器官衰竭不再是死刑。

哪些技術突破正在加速該領域的創新？

再生醫學、生醫材料、人工智慧診斷和機器人技術的突破推動了人造器官和仿生學的創新。生物列印技術正在創建模擬自然組織特性的血管化器官結構。組織工程的進步現在允許將實驗室培育的皮膚、角膜甚至軟骨與人造植入整合。由腦機介面 (BMI) 驅動的神經連接義肢可以透過思想實現直覺控制，為截肢者和脊髓損傷患者開闢了新的可能性。義肢中嵌入的感測器提供即時回饋，例如握力和表面紋理，從而顯著改善使用者體驗。在人工心臟和輔助人工心臟中，磁浮轉子和節能馬達提高了安全性並延長了裝置的使用壽命。碳纖維複合材料和基於人工智慧的運動模式識別正在使穿戴式仿生設備（包括動力服裝）更輕、更實惠。奈米塗層和抗菌表面可提高植入的生物相容性，並降低感染風險。隨著機器學習演算法日益複雜，它們將能夠動態調整胰島素幫浦、心律調節器和腎臟輔助裝置，從而提供個人化性能，並帶來醫療保健方面的預測性洞察。

社會、道德和經濟因素會影響市場趨勢嗎？

隨著人工器官和仿生學市場日趨成熟，其發展軌跡日益受到社會接受度、倫理爭議和報銷政策的影響。隨著仿生肢體和人工胰腺系統的成功案例出現在主流媒體，社會意識正在不斷提升，但關於人類增強、身份認同和可及性的倫理問題仍然存在。修復和增強之間的界限日益模糊，引發了關於「正常」健康定義的爭論。成本仍然是一個重大障礙，尤其是在發展中地區，這些地區獲得先進義肢和植入式設備的管道仍然有限。儘管許多國家醫療保險體系面臨著為這些昂貴技術提供更大覆蓋範圍的壓力，但預算限制仍然存在。此外，缺乏訓練有素的專業人員來處理複雜的仿生系統，尤其是在移植後復健方面。全球醫療保健差距正在影響這些技術的應用範圍和方式。同時，患者權益組織呼籲加速救生設備的監管核准。儘管政府和非政府組織為研究提供資金和補貼的努力正在取得進展，但其廣泛應用仍然是一項挑戰。在創新、道德和可負擔性之間取得平衡可能是充分發揮這一轉變潛力的關鍵。

人工器官和仿生學市場的成長受到多種因素的推動。

慢性病和退化性疾病發生率上升、全球器官捐贈者短缺以及醫療技術創新投資增加，推動了對腎臟替代療法、心血管植入和助聽器的需求。全球老化，尤其是歐洲和日本的老化，導致對腎臟替代療法、心血管植入物和助聽器的需求激增。技術進步使這些設備更加精確、緊湊和可靠，從而刺激了醫療保健提供者對其的採用。在新興市場，醫療基礎設施的改善和保險覆蓋範圍的擴大正在推動市場滲透。在復健領域，醫療和軍事部門對穿戴式仿生外骨骼的需求都在增加。消費者行為也在發生變化，患者越來越了解情況，並且願意採用能夠改善其生活方式和自主性的身體整合技術。在高所得市場中，選擇性使用仿生解決方案來增強行動性和功能性也正在興起。醫療機構和高科技公司之間的研究合作正在加速原型製作、測試和商業化。新的模式正在利用雲端基礎的健康數據整合來實現遠端監控和預測性護理，這使得它們對遠端醫療平台特別有吸引力。在監管支援和強大的創新管道的支持下，這些趨勢正在鞏固市場的上升趨勢。

部分

產品類型（人工器官、人工仿生）；技術（機械仿生技術、電子仿生技術）

受訪公司範例

  • Abiomed, Inc.
  • Asahi Kasei Medical Co., Ltd.
  • Berlin Heart GmbH
  • Bornlife Prosthetic and Orthotic Inc.
  • Boston Scientific Corporation
  • Cochlear Ltd.
  • Edwards Lifesciences Corporation
  • Ekso Bionics Holdings Inc.
  • Getinge AB（Getinge Group）
  • Jarvik Heart, Inc.
  • Medtronic PLC
  • Ossur
  • Sonova
  • SynCardia Systems, LLC
  • Zimmer Biomet Holdings, Inc.

人工智慧整合

全球產業分析師正在利用可操作的專家內容和人工智慧工具改變市場和競爭情報。

Global 特定產業產業SLM 的典型規範，而是建立了一個從世界各地專家收集的內容庫，包括影片錄影、部落格、搜尋引擎研究以及大量的公司、產品/服務和市場數據。

關稅影響係數

全球產業分析師根據公司總部所在國家、製造地和進出口（成品和原始設備製造商）情況預測其競爭地位的變化。這種複雜而多面的市場動態預計將以多種方式影響競爭對手，包括銷貨成本(COGS) 上升、盈利下降、供應鏈重組以及其他微觀和宏觀市場動態。

目錄

第1章調查方法

第2章執行摘要

  • 市場概覽
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 其他歐洲國家
  • 亞太地區
  • 其他地區

第4章 競賽

簡介目錄
Product Code: MCP29287

Global Artificial Organs and Bionics Market to Reach US$71.0 Billion by 2030

The global market for Artificial Organs and Bionics estimated at US$43.2 Billion in the year 2024, is expected to reach US$71.0 Billion by 2030, growing at a CAGR of 8.6% over the analysis period 2024-2030. Artificial Organs, one of the segments analyzed in the report, is expected to record a 10.0% CAGR and reach US$45.1 Billion by the end of the analysis period. Growth in the Artificial Bionics segment is estimated at 6.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$11.4 Billion While China is Forecast to Grow at 8.3% CAGR

The Artificial Organs and Bionics market in the U.S. is estimated at US$11.4 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$11.3 Billion by the year 2030 trailing a CAGR of 8.3% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 8.1% and 7.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 6.7% CAGR.

Global "Artificial Organs And Bionics" Market - Key Trends & Drivers Summarized

How Are Artificial Organs And Bionics Redefining Human Longevity And Functionality?

Artificial organs and bionics are revolutionizing the landscape of modern medicine by offering life-saving and life-enhancing alternatives for patients with failing organs or lost bodily functions. From artificial hearts and kidneys to cochlear implants and bionic limbs, this sector merges biomedical engineering with robotics, electronics, and advanced materials. Artificial organs serve as vital bridges to transplants or long-term solutions where donor shortages persist. Bionics, meanwhile, restore movement, hearing, or vision-enabling patients to regain independence and quality of life. These innovations are especially critical for aging populations, where chronic diseases are prevalent. The integration of neural interfaces, haptic feedback, and real-time monitoring has made modern bionics more responsive and lifelike than ever before. Exoskeletons for rehabilitation and mobility in paraplegic patients, as well as 3D-printed organ scaffolds, are pushing boundaries previously thought impossible. Continuous improvement in miniaturization, battery life, and implantable biosensors is creating smarter, more patient-adaptive devices. This convergence of disciplines is moving healthcare toward a future where disability is no longer a permanent limitation, and organ failure no longer a death sentence.

What Technological Breakthroughs Are Accelerating Innovation In This Field?

Innovation in artificial organs and bionics is being propelled by breakthroughs in regenerative medicine, biomaterials, AI-enabled diagnostics, and robotics. Bio-printing technologies are enabling the creation of vascularized organ structures that can mimic natural tissue properties. Advances in tissue engineering now allow lab-grown skin, corneas, and even cartilage to be integrated with synthetic implants. Neural-linked prosthetics, driven by brain-machine interfaces (BMIs), enable intuitive control through thought, opening new possibilities for amputees and spinal cord injury patients. Sensors embedded in prosthetic limbs provide real-time feedback, such as grip strength or surface texture, which significantly improves user experience. In artificial hearts and ventricular assist devices (VADs), magnetically levitated rotors and energy-efficient motors have enhanced safety and extended device longevity. Wearable bionics, including powered exosuits, are becoming lighter and more affordable thanks to carbon fiber composites and AI-based motion pattern recognition. Nanocoatings and antimicrobial surfaces are improving the biocompatibility of implants, reducing infection risks. As machine learning algorithms become more sophisticated, they are enabling dynamic adjustments in insulin pumps, pacemakers, and renal assist devices, offering personalized performance with predictive healthcare insights.

Are Societal, Ethical, And Economic Factors Influencing Market Trajectory?

As the artificial organ and bionics market matures, its trajectory is increasingly shaped by social acceptance, ethical debates, and reimbursement policies. Public perception is evolving as success stories of bionic limbs or artificial pancreas systems enter mainstream media, but ethical questions about human enhancement, identity, and access remain. The line between restoration and augmentation is blurring, leading to debates on what constitutes “normal” health. Cost remains a critical barrier, especially in developing regions, where access to advanced prosthetics and implantable devices is still limited. Health insurance systems in many countries are under pressure to cover more of these expensive technologies, yet budget constraints remain. There’s also a shortage of trained professionals to handle complex bionic systems, particularly in post-implantation rehabilitation. Global health disparities are influencing where and how these technologies are adopted. Meanwhile, patient advocacy groups are demanding faster regulatory approvals for life-saving devices. Efforts by governments and NGOs to fund research and offer subsidies are gaining momentum, but widespread accessibility remains a challenge. Balancing innovation, ethics, and affordability will be key to unlocking the full potential of this transformative sector.

The Growth In The Artificial Organs And Bionics Market Is Driven By Several Factors…

…including the rising prevalence of chronic and degenerative diseases, the global shortage of organ donors, and increasing investments in medical innovation. The aging global population, particularly in Europe and Japan, is contributing to a surge in demand for renal replacement therapies, cardiovascular implants, and hearing aids. Technological readiness has made these devices more accurate, compact, and reliable, encouraging adoption among healthcare providers. In emerging economies, rising healthcare infrastructure and growing insurance coverage are facilitating market penetration. The rehabilitation sector is expanding with demand for wearable bionic exoskeletons in both medical and military settings. Consumer behavior is shifting, too-patients are increasingly informed and open to adopting body-integrated technologies that enhance lifestyle and autonomy. In high-income markets, elective use of bionic solutions for athletic performance or functional enhancement is also emerging. Research collaborations between medical institutions and tech firms are leading to faster prototyping, testing, and commercialization. The availability of cloud-based health data integration in newer models allows remote monitoring and predictive care, which is particularly attractive to telemedicine platforms. These trends, underpinned by regulatory support and a strong innovation pipeline, are solidifying the market’s upward trajectory.

SCOPE OF STUDY:

The report analyzes the Artificial Organs and Bionics market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product Type (Artificial Organs, Artificial Bionics); Technology (Mechanical Bionics Technology, Electronic Bionics Technology)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 33 Featured) -

  • Abiomed, Inc.
  • Asahi Kasei Medical Co., Ltd.
  • Berlin Heart GmbH
  • Bornlife Prosthetic and Orthotic Inc.
  • Boston Scientific Corporation
  • Cochlear Ltd.
  • Edwards Lifesciences Corporation
  • Ekso Bionics Holdings Inc.
  • Getinge AB (Getinge Group)
  • Jarvik Heart, Inc.
  • Medtronic PLC
  • Ossur
  • Sonova
  • SynCardia Systems, LLC
  • Zimmer Biomet Holdings, Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Artificial Organs and Bionics - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Organ Failure Cases Drive Demand for Artificial Organs
    • Technological Innovations in Bionic Limbs Improve Mobility and Quality of Life
    • Increased Investment in 3D Bioprinting of Tissues Accelerates Market Expansion
    • Growing Use of Neural Interfaces in Bionics Enhances Functional Capabilities
    • Shortage of Organ Donors Boosts Development of Artificial Alternatives
    • Surging Demand for Wearable and Implantable Health Devices Fuels Bionic Integration
    • Advancements in Smart Prosthetics Offer Customization and Real-Time Feedback
    • Expanding Application in Military and Rehabilitation Drives Innovation
    • Insurance Coverage for Artificial Organs Encourages Patient Adoption
    • Emergence of Soft Robotics in Artificial Organ Development Improves Biocompatibility
    • AI-Driven Control Systems in Bionics Enhance Patient Outcomes
    • Growing Geriatric Population with Chronic Organ Diseases Supports Long-Term Growth
    • Cross-Sector Collaborations in Biotech and Engineering Foster Breakthroughs
    • Global Expansion of Transplant Centers and Medical Facilities Drives Market Reach
    • Increased Funding from Government and Private Institutions Spurs R&D Progress
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Artificial Organs and Bionics Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Artificial Organs and Bionics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World 6-Year Perspective for Artificial Organs and Bionics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Artificial Organs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 5: World 6-Year Perspective for Artificial Organs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 6: World Recent Past, Current & Future Analysis for Artificial Bionics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 7: World 6-Year Perspective for Artificial Bionics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Mechanical Bionics Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World 6-Year Perspective for Mechanical Bionics Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Electronic Bionics Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 11: World 6-Year Perspective for Electronic Bionics Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Artificial Organs and Bionics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 12: USA Recent Past, Current & Future Analysis for Artificial Organs and Bionics by Product Type - Artificial Organs and Artificial Bionics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 13: USA 6-Year Perspective for Artificial Organs and Bionics by Product Type - Percentage Breakdown of Value Sales for Artificial Organs and Artificial Bionics for the Years 2025 & 2030
    • TABLE 14: USA Recent Past, Current & Future Analysis for Artificial Organs and Bionics by Technology - Mechanical Bionics Technology and Electronic Bionics Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 15: USA 6-Year Perspective for Artificial Organs and Bionics by Technology - Percentage Breakdown of Value Sales for Mechanical Bionics Technology and Electronic Bionics Technology for the Years 2025 & 2030
  • CANADA
    • TABLE 16: Canada Recent Past, Current & Future Analysis for Artificial Organs and Bionics by Product Type - Artificial Organs and Artificial Bionics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 17: Canada 6-Year Perspective for Artificial Organs and Bionics by Product Type - Percentage Breakdown of Value Sales for Artificial Organs and Artificial Bionics for the Years 2025 & 2030
    • TABLE 18: Canada Recent Past, Current & Future Analysis for Artificial Organs and Bionics by Technology - Mechanical Bionics Technology and Electronic Bionics Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 19: Canada 6-Year Perspective for Artificial Organs and Bionics by Technology - Percentage Breakdown of Value Sales for Mechanical Bionics Technology and Electronic Bionics Technology for the Years 2025 & 2030
  • JAPAN
    • Artificial Organs and Bionics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 20: Japan Recent Past, Current & Future Analysis for Artificial Organs and Bionics by Product Type - Artificial Organs and Artificial Bionics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 21: Japan 6-Year Perspective for Artificial Organs and Bionics by Product Type - Percentage Breakdown of Value Sales for Artificial Organs and Artificial Bionics for the Years 2025 & 2030
    • TABLE 22: Japan Recent Past, Current & Future Analysis for Artificial Organs and Bionics by Technology - Mechanical Bionics Technology and Electronic Bionics Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 23: Japan 6-Year Perspective for Artificial Organs and Bionics by Technology - Percentage Breakdown of Value Sales for Mechanical Bionics Technology and Electronic Bionics Technology for the Years 2025 & 2030
  • CHINA
    • Artificial Organs and Bionics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 24: China Recent Past, Current & Future Analysis for Artificial Organs and Bionics by Product Type - Artificial Organs and Artificial Bionics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 25: China 6-Year Perspective for Artificial Organs and Bionics by Product Type - Percentage Breakdown of Value Sales for Artificial Organs and Artificial Bionics for the Years 2025 & 2030
    • TABLE 26: China Recent Past, Current & Future Analysis for Artificial Organs and Bionics by Technology - Mechanical Bionics Technology and Electronic Bionics Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 27: China 6-Year Perspective for Artificial Organs and Bionics by Technology - Percentage Breakdown of Value Sales for Mechanical Bionics Technology and Electronic Bionics Technology for the Years 2025 & 2030
  • EUROPE
    • Artificial Organs and Bionics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 28: Europe Recent Past, Current & Future Analysis for Artificial Organs and Bionics by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 29: Europe 6-Year Perspective for Artificial Organs and Bionics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
    • TABLE 30: Europe Recent Past, Current & Future Analysis for Artificial Organs and Bionics by Product Type - Artificial Organs and Artificial Bionics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 31: Europe 6-Year Perspective for Artificial Organs and Bionics by Product Type - Percentage Breakdown of Value Sales for Artificial Organs and Artificial Bionics for the Years 2025 & 2030
    • TABLE 32: Europe Recent Past, Current & Future Analysis for Artificial Organs and Bionics by Technology - Mechanical Bionics Technology and Electronic Bionics Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Europe 6-Year Perspective for Artificial Organs and Bionics by Technology - Percentage Breakdown of Value Sales for Mechanical Bionics Technology and Electronic Bionics Technology for the Years 2025 & 2030
  • FRANCE
    • Artificial Organs and Bionics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 34: France Recent Past, Current & Future Analysis for Artificial Organs and Bionics by Product Type - Artificial Organs and Artificial Bionics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 35: France 6-Year Perspective for Artificial Organs and Bionics by Product Type - Percentage Breakdown of Value Sales for Artificial Organs and Artificial Bionics for the Years 2025 & 2030
    • TABLE 36: France Recent Past, Current & Future Analysis for Artificial Organs and Bionics by Technology - Mechanical Bionics Technology and Electronic Bionics Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 37: France 6-Year Perspective for Artificial Organs and Bionics by Technology - Percentage Breakdown of Value Sales for Mechanical Bionics Technology and Electronic Bionics Technology for the Years 2025 & 2030
  • GERMANY
    • Artificial Organs and Bionics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 38: Germany Recent Past, Current & Future Analysis for Artificial Organs and Bionics by Product Type - Artificial Organs and Artificial Bionics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Germany 6-Year Perspective for Artificial Organs and Bionics by Product Type - Percentage Breakdown of Value Sales for Artificial Organs and Artificial Bionics for the Years 2025 & 2030
    • TABLE 40: Germany Recent Past, Current & Future Analysis for Artificial Organs and Bionics by Technology - Mechanical Bionics Technology and Electronic Bionics Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 41: Germany 6-Year Perspective for Artificial Organs and Bionics by Technology - Percentage Breakdown of Value Sales for Mechanical Bionics Technology and Electronic Bionics Technology for the Years 2025 & 2030
  • ITALY
    • TABLE 42: Italy Recent Past, Current & Future Analysis for Artificial Organs and Bionics by Product Type - Artificial Organs and Artificial Bionics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 43: Italy 6-Year Perspective for Artificial Organs and Bionics by Product Type - Percentage Breakdown of Value Sales for Artificial Organs and Artificial Bionics for the Years 2025 & 2030
    • TABLE 44: Italy Recent Past, Current & Future Analysis for Artificial Organs and Bionics by Technology - Mechanical Bionics Technology and Electronic Bionics Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Italy 6-Year Perspective for Artificial Organs and Bionics by Technology - Percentage Breakdown of Value Sales for Mechanical Bionics Technology and Electronic Bionics Technology for the Years 2025 & 2030
  • UNITED KINGDOM
    • Artificial Organs and Bionics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 46: UK Recent Past, Current & Future Analysis for Artificial Organs and Bionics by Product Type - Artificial Organs and Artificial Bionics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 47: UK 6-Year Perspective for Artificial Organs and Bionics by Product Type - Percentage Breakdown of Value Sales for Artificial Organs and Artificial Bionics for the Years 2025 & 2030
    • TABLE 48: UK Recent Past, Current & Future Analysis for Artificial Organs and Bionics by Technology - Mechanical Bionics Technology and Electronic Bionics Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 49: UK 6-Year Perspective for Artificial Organs and Bionics by Technology - Percentage Breakdown of Value Sales for Mechanical Bionics Technology and Electronic Bionics Technology for the Years 2025 & 2030
  • REST OF EUROPE
    • TABLE 50: Rest of Europe Recent Past, Current & Future Analysis for Artificial Organs and Bionics by Product Type - Artificial Organs and Artificial Bionics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Rest of Europe 6-Year Perspective for Artificial Organs and Bionics by Product Type - Percentage Breakdown of Value Sales for Artificial Organs and Artificial Bionics for the Years 2025 & 2030
    • TABLE 52: Rest of Europe Recent Past, Current & Future Analysis for Artificial Organs and Bionics by Technology - Mechanical Bionics Technology and Electronic Bionics Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 53: Rest of Europe 6-Year Perspective for Artificial Organs and Bionics by Technology - Percentage Breakdown of Value Sales for Mechanical Bionics Technology and Electronic Bionics Technology for the Years 2025 & 2030
  • ASIA-PACIFIC
    • Artificial Organs and Bionics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 54: Asia-Pacific Recent Past, Current & Future Analysis for Artificial Organs and Bionics by Product Type - Artificial Organs and Artificial Bionics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 55: Asia-Pacific 6-Year Perspective for Artificial Organs and Bionics by Product Type - Percentage Breakdown of Value Sales for Artificial Organs and Artificial Bionics for the Years 2025 & 2030
    • TABLE 56: Asia-Pacific Recent Past, Current & Future Analysis for Artificial Organs and Bionics by Technology - Mechanical Bionics Technology and Electronic Bionics Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Asia-Pacific 6-Year Perspective for Artificial Organs and Bionics by Technology - Percentage Breakdown of Value Sales for Mechanical Bionics Technology and Electronic Bionics Technology for the Years 2025 & 2030
  • REST OF WORLD
    • TABLE 58: Rest of World Recent Past, Current & Future Analysis for Artificial Organs and Bionics by Product Type - Artificial Organs and Artificial Bionics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 59: Rest of World 6-Year Perspective for Artificial Organs and Bionics by Product Type - Percentage Breakdown of Value Sales for Artificial Organs and Artificial Bionics for the Years 2025 & 2030
    • TABLE 60: Rest of World Recent Past, Current & Future Analysis for Artificial Organs and Bionics by Technology - Mechanical Bionics Technology and Electronic Bionics Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 61: Rest of World 6-Year Perspective for Artificial Organs and Bionics by Technology - Percentage Breakdown of Value Sales for Mechanical Bionics Technology and Electronic Bionics Technology for the Years 2025 & 2030

IV. COMPETITION